Evonik has published the first edition of the MetAMINO® ATLAS, a report displaying the results of 15 performance trials that investigated the relative bioavailability of supplementary methionine sources in animal diets.
"For cost-effective purchasing, feed formulation and animal production, precise knowledge about the relative nutritive value of DLmethionine compared with liquid MHA-FA and MHA-Ca is essential," said Dr. Jan-Olaf Barth, head of the Efficient Nutrition product line at Evonik. "With the MetAMINO® ATLAS, we want to support our business partners in making knowledge-based purchase decisions for sustainable and economical livestock operations."
The trials were conducted in 11 countries on five continents under different climatic, geographic and farm conditions - in experimental settings as well as at commercial farms with broiler chickens, laying hens, swine and aqua species.
"Across all trials and all species, we found that comparable animal performance criteria were achieved when 100 units of MHA-products were replaced with 65 units of MetAMINO®," said Nils Niedner, product manager of MetAMINO®.
The MetAMINO® ATLAS 2022 further includes a selection of latest scientific articles, conference abstracts and peer reviewed publications concerning the bio-efficacy of the commercially available methionine forms.
Interested parties can access the complete paper via the following link:
Visit Evonik at: www.evonik.com/animal-nutrition